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Abstract
BACKGROUND: Terminal intensive care unit (ICU) stays represent an important target to increase value of
care.
OBJECTIVE: To characterize patterns of daily costs of ICU care at the end of life and, based on these
patterns, examine the role for palliative care interventions in enhancing value.
DESIGN: Secondary analysis of an intervention study to improve quality of care for critically ill patients.
SETTING/PATIENTS: 572 patients who died in the ICU between 2003 and 2005 at a Level-1 trauma center.
METHODS: Data were linked with hospital financial records. Costs were categorized into direct fixed, direct
variable, and indirect costs. Patterns of daily costs were explored using generalized estimating equations
stratified by length of stay, cause of death, ICU type, and insurance status. Estimates from the literature of
effects of palliative care interventions on ICU utilization were used to simulate potential cost savings under
different time horizons and reimbursement models.
MAIN RESULTS: Mean cost for a terminal ICU stay was 39.3K ± 45.1K. Direct fixed costs represented 45%
of total hospital costs, direct variable costs 20%, and indirect costs 34%. Day of admission was most expensive
(mean 9.6K ± 7.6K); average cost for subsequent days was 4.8K ± 3.4K and stable over time and patient
characteristics.
CONCLUSIONS: Terminal ICU stays display consistent cost patterns across patient characteristics. Savings
can be realized with interventions that align care with patient preferences, helping to prevent unwanted ICU
utilization at end of life. Cost modeling suggests that implications vary depending on time horizon and
reimbursement models.
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Abstract
Background: Terminal intensive care unit (ICU) stays represent an important target to increase value of care.
Objective: To characterize patterns of daily costs of ICU care at the end of life and, based on these patterns,
examine the role for palliative care interventions in enhancing value.
Design: Secondary analysis of an intervention study to improve quality of care for critically ill patients.
Setting/Patients: 572 patients who died in the ICU between 2003 and 2005 at a Level-1 trauma center.
Methods: Data were linked with hospital financial records. Costs were categorized into direct fixed, direct
variable, and indirect costs. Patterns of daily costs were explored using generalized estimating equations
stratified by length of stay, cause of death, ICU type, and insurance status. Estimates from the literature of
effects of palliative care interventions on ICU utilization were used to simulate potential cost savings under
different time horizons and reimbursement models.
Main Results: Mean cost for a terminal ICU stay was 39.3K – 45.1K. Direct fixed costs represented 45% of
total hospital costs, direct variable costs 20%, and indirect costs 34%. Day of admission was most expensive
(mean 9.6K – 7.6K); average cost for subsequent days was 4.8K – 3.4K and stable over time and patient
characteristics.
Conclusions: Terminal ICU stays display consistent cost patterns across patient characteristics. Savings can be
realized with interventions that align care with patient preferences, helping to prevent unwanted ICU utilization
at end of life. Cost modeling suggests that implications vary depending on time horizon and reimbursement
models.
Introduction
In the United States, *20% of patients die during ahospitalization with an intensive care unit (ICU) stay.1
Critical care costs are estimated to exceed $82 billion annu-
ally, accounting for 13% of inpatient hospital costs.2,3 It is not
surprising that strategies that target reducing costs in the ICU
are of great interest. One area of focus for this cost reduction
is the costs of end-of-life care in the ICU. Despite the rela-
tively high proportion of patients who die in the ICU, most
patients would prefer to die at home if diagnosed with a life-
limiting illness.4,5 This raises the potential for simultaneously
improving quality of care through palliative care services or
advance care planning (ACP) by matching patient’s prefer-
ences with care received, and reducing intensity and costs of
care at the end of life.
However, the potential ICU cost savings associated with
improving palliative care and the incentive to realize these
savings may vary depending on the perspective (hospital,
payer, society), the reimbursement models (fee-for-service,
bundled payment, value-based purchasing, capitated system),
and the time horizon (short term with a range from days to
months vs. long-term range of years). As our reimbursement
models incorporate more value-based purchasing, capitated
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payment systems, and population-based payment models, and
less volume-based fee-for-service, the implications of efforts
to reduce costs of end-of-life care in the ICU may shift.
Interventions such as ACP and palliative care consultation
that seek to improve decision-making among clinicians, pa-
tients, and families may have different economic implica-
tions for terminal ICU stays in different reimbursement
models. Modeling potential cost savings from these types of
interventions requires an understanding of the patterns and
distribution of costs for patients who die in the ICU. For
example, shortening length of stay (LOS) is often advocated
as a target for cost-saving interventions. However, whether or
not significant cost savings can be achieved by shortening
LOS in the ICU has been debated.6–9 The impact of reducing
ICU LOS will vary depending on the proportion of costs that
are fixed and the reimbursement model.
The objective of this study was to describe the patterns and
breakdown of daily ICU costs in a cohort of patients who died
in the ICU to better understand expenditures related to ter-
minal ICU stays and the potential influence of palliative care
services or ACP. We describe the variation in total daily costs
by ICU day and report the proportion of total costs that were
direct variable, direct fixed, and indirect costs. Direct variable
costs include supply and drug costs and are responsive to
patient characteristics and volume. Direct fixed costs, such as
labor (nursing, medical assistants, etc.), are fixed in the short
term. Indirect costs are not directly linked to patient care
(i.e., information technology and environmental services).
We further explore the pattern of costs by LOS, cause of
death, clinical service, type of ICU, and insurance status. In
particular, we test two hypotheses for each of these groups:
(1) on average, costs are greater the first ICU day than the
second day; and (2) on average, costs are stable after the
second day. In addition, we examine whether the patterns of
costs are similar across different diseases, different types of
ICUs, and across different physician disciplines. We dem-
onstrate how these results can be used to simulate what cost
savings could look like on both short and long time horizons
if interventions that reduce or shorten unwanted ICU utiliza-
tion were implemented. Our goal is to provide insights for
clinicians, healthcare systems, and policy makers on the im-
plications of cost savings regarding end-of-life care in the ICU.
Methods
Design overview
Data were collected as part of an interdisciplinary multi-
faceted intervention to improve the quality of end-of-life care
for critically ill patients and their families.10–12 Eligible pa-
tients were adults who had died in an ICU between 2003 and
2005 after a minimum stay of 6 hours. The study setting was a
university-affiliated 413-bed Level-1 trauma center. There
were 88 ICU beds distributed among five ICUs (medical/
cardiac, trauma/surgical, neurology/neurosurgical, burn, and
pediatric). The institutional review board approved this study
(UW HSC#23503).
Data collection
Trained chart abstractors using a standardized chart ab-
straction protocol reviewed eligible patients’ medical records
to obtain demographic (age, gender, type of insurance) and
clinical information (diagnoses, ICU, and hospital LOS, code
status, life-sustaining treatments). Patient race, education,
and cause of death were determined from death certificates.
Abstracted data were linked to hospital financial records to
obtain detailed cost information.
Predictors/strata
The pattern of costs was stratified by cause of death, clinical
service, type of ICU, and insurance status. Cause of death was
divided into trauma, cancer, cardiac, respiratory, neurological,
and other. Clinical service was grouped into general surgery,
medicine, neurology, neurosurgery, and other. Type of ICU
included neurology, medicine, pediatric, coronary, burn, trau-
ma, and surgical. Insurance was grouped into private, Medi-
care, other government funded, and other/none/unknown.
Outcomes
Costs were used instead of charges since charges bear little
resemblance to economic cost, and use of charges as a proxy
for economic cost may lead to unwarranted conclusions about
economic efficiency.13 These costs were abstracted by hospital
financial analysts directly from patient accounts and represent
the total costs for all services provided on each hospital day,
including overhead costs, labor costs, and supply costs. In the
accounting system, cost components are grouped into 3 cate-
gories: direct variable, direct fixed, and indirect. These cate-
gories allowed us to capture which costs could change in the
short term or the long term. Direct costs represent costs that are
traceable to a specific cost center providing direct patient care,
such as pharmacy, radiology, respiratory care, laboratory, and
microbiology. Direct variable costs include supply and drug
costs and are the most responsive to individual patient char-
acteristics such as severity of illness and reason for admission.
Direct fixed costs include labor, clinical department adminis-
tration, and overhead fees. These types of costs are fixed in the
short term, but responsive to patient volume in the long term.
For example, wages and contracts are set for the year, but if
bed occupancy decreases over time, new contracts with fewer
staff or hours could be written. Indirect costs, which are in-
cluded in the patient bill, represent services provided by cost
centers not directly linked to patient care, such as information
technology and environmental services. These types of costs
are the least amenable to change based on patient character-
istics or bed occupancy.
This institution uses the McKesson Explorer platform for
hospital accounting; physician fees are generated from a
separate organization and were not included in this analysis
because they were not available at the ICU-day level. All
costs were adjusted for inflation and compared at the 2013 US
dollar value.
Statistical analysis
Patterns of ICU costs. To describe the patterns of total
cost over an ICU stay, we examined the average total cost and
breakdown by day of stay. The daily pattern and breakdown
of costs were then stratified by LOS, cause of death, clinical
service, type of ICU, and insurance status. We used gen-
eralized estimating equations with independent working
correlation matrices to test whether costs were higher on day
1 than day 2 and whether costs were stable thereafter.14 The
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first question was addressed by comparing the ratio of average
ICU costs between days 1 and 2. The second question was
addressed using an equivalence test of the linear trend in av-
erage costs after day 2. This test examines the strength of
evidence that average ICU costs do not change by more than
25% per week after day 2. This cutoff was chosen to reflect an
approximate change in daily costs of about $400 a week; any
change in daily costs above this was considered clinically
meaningful. We performed this test separately in various pa-
tient groups defined by covariate levels to see if the trend was
constant across patient groups. Details on the regression model
and testing procedures are in Appendix A. All analyses were
conducted using R3.1.0 (https://cran.r-project.org/).
Potential cost savings. To estimate cost savings that
might be associated with the use of ACP and palliative care
consultation, we conducted simulations using the patterns
and distribution of costs identified in this sample and current
estimates of reductions in ICU utilization associated with
ACP (37% fewer ICU admissions) and palliative care con-
sultation (26% shorter LOS).15,16 We estimate savings based
on short and long time horizons.
Results
Five hundred and seventy-two patients were included in
our sample. The average age was 61 – 18 years. About 90% of
patients were intubated in the last week of life, with 19%
dying without any withdrawal of life support. The median
ICU LOS was 3 days (interquartile range [IQR]: 1–8). Ad-
ditional patient characteristics are displayed in Table 1.
Patterns of cost distributions
The average total ICU cost per patient was 39.3K – 45.1K
(median 24.1K; IQR 10.4–51.9). Direct fixed costs represented
45% of total hospital costs; direct variable costs were 20%; and
indirect costs were 34% of hospital costs. The detailed break-
down of subcategories is displayed in Figure 1. Patients with an
ICU LOS of only one day had a higher percentage of supply
costs (23.2%) and lower percentage of labor costs (33.3%) than
patients with longer ICU stays (15.7% and 39.8% for supply
and labor, respectively). High total ICU costs were associated
with a higher percentage of costs represented by supplies
(correlation = 0.09, p = 0.02) with 17.3% in the upper tertile of
total ICU costs compared with 11.8% in the lower tertile.
Over the length of the ICU stay, the proportion of total
costs that were represented by labor increased slightly from
35% to 43% by week 2 and were offset by a decrease in
proportion of costs attributable to supplies from 21% to 12%.
The remaining categories stayed relatively constant.
The average cost of an ICU day over the entire LOS was
7.7K – 6.1K (median 6.1K; IQR 4.9–8.4). Day of admission
was the most expensive (mean 9.6K – 7.6K; median 6.9K
[IQR 5.2–11.0]). The average cost per day after admission
was 4.8K – 3.4K (median 4.3K; IQR 3.5–5.5) (Table 2).
Mean daily costs beginning with day of admission, broken
down by category of cost, are displayed in Figure 2. The day
before death was similar in expense to all other days, ex-
cluding admission day.
This pattern of admission day being the most expensive
and subsequent days having stable costs was consistent across
patients and differed by clinical service, type of ICU, and
insurance status (Fig. 3). This pattern was consistent across
causes of death. It was also consistent across ICU LOS,
provided LOS was ‡7 days. For patients with LOS <7 days,
admission day was still the most expensive; however, there
was a slight trend of decreasing costs from days 2 through 7.
Table 1. Characteristics of Cohort
Characteristic
All Subjects
(n = 572)
Age at time of death 61.5 – 17.7
Females, n (%) 193 (33.7%)
Race/ethnicity
White 437 (80.5%)
Black 34 (6.3%)
Asian 39 (7.2%)
Hispanic 21 (3.9%)
Other 12 (2.2%)
Level of education
<8th grade 49 (9.1%)
Some high school 67 (12.4%)
HS/GED 209 (38.6%)
Some college 119 (22.0%)
Four-year college 70 (12.9%)
Graduate level 27 (5.0%)
ICU length of stay, median (IQR) 3.00 (1.00–8.00)
Hospital length of stay, median (IQR) 4.00 (1.00–11.00)
Diagnosisa
Heart disease 31 (5.4%)
HIV/infection 55 (9.6%)
Respiratory 33 (5.8%)
GI/liver 26 (4.5%)
Stroke/neuro 150 (26.2%)
Trauma 63 (11.0%)
Cancer 5 (0.9%)
Unknown/other 210 (36.6%)
Cause of deathb
Trauma 164 (28.7%)
Cancer 20 (3.5%)
Cardiovascular/cardiac 76 (13.3%)
Respiratory 39 (6.8%)
Neurological 123 (21.5%)
Other 149 (26.0%)
Intubated in last week of life 521 (91.1%)
Died in setting of full support 111 (19.4%)
DNR in place at time of death 501 (87.7%)
Invasive mechanical ventilation
or BiPAP discontinued before death
406 (75.6%)
CPR in last 24 hours of life 67 (11.7%)
Documentation of a living
will before admitc
117 (38.1%)
Type of insurance
Private 106 (18.5%)
Medicare 282 (49.3%)
Other Government 109 (19.1%)
Other/none/unknown 75 (13.1%)
Postinterventiond 324 (56.5%)
Data presented as mean – SD or n (%), unless otherwise indicated.
aDetermined by first ICD-9 code listed; this reflects most
reimbursable, not necessarily primary, diagnosis.
bAs reported on death certificate using ICD-10 coding.
cProportion of patients with medical record documentation of a
living will (n = 307).
dPatients who died after implementation of the intervention to
improve palliative care in the ICU (10–12).
BiPAP, bilevel positive airway pressure; ICU, intensive care unit;
IQR, interquartile range.
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Projecting cost reductions with palliative
care interventions
To illustrate the potential cost savings of these interven-
tions, we applied estimates of ACP and palliative care in-
tervention effects to the costs described above for a
representative patient in our cohort who died from compli-
cations of chronic obstructive pulmonary disease (COPD)
who would have preferred to die at home. Preventing the 6.5-
day ICU admission with ACP would immediately save the
hospital $6,200 in direct variable costs. Over time, if ICU bed
occupancy decreased as a result of ACP and the alignment of
patient preferences at the end of life with care received, the direct
fixed costs could also be saved, adding on average, an addi-
tional $18,400 in savings to the hospital per patient (Table 3).
If this representative patient was admitted to the ICU and
received ICU-based palliative care intervention of average
effectiveness, the LOS could be reduced by an estimated
26%, or 1.7 days. In the short term, this would have led to
$1,300 per patient in immediate direct variable cost savings
for the hospital. If the palliative care intervention was
widespread, in the long term, ceteris paribus, as bed occu-
pancy rates decline, another $2,800 per patient in direct fixed
costs may be saved (Table 3). It is important to note that these
figures are ICU costs avoided and do not take into account the
costs incurred through the alternative care received, whether
at home or in the hospital. Thus, these figures represent the
upper bound of potential cost saving.
The degree of savings is thus determined by the time
horizon—short versus long term. The incentive, however, for
hospitals to realize these savings varies depending on the
reimbursement model with increasing incentive as we move
from fee-for-service toward capitated payment models.
Discussion
Our findings demonstrated that (1) the first ICU day was
the most expensive with the days in between admission and
death having relatively stable costs; (2) this pattern was
consistent across patients regardless of clinical service, in-
surance status, type of ICU, or cause of death; (3) direct
variable costs accounted for *20% of ICU costs; this per-
centage decreased over time; (4) direct fixed and indirect
costs constituted *45% and 35% of ICU costs, respectively,
these percentages increased slightly over time; and (5) high
total ICU costs were associated with a higher percentage of
direct variable costs (represented primarily by supplies). To
our knowledge, this is the first study evaluating the pattern
and breakdown of ICU costs by day of stay for patients who
died in the ICU, and our findings demonstrate the stability of
the pattern across a diverse group of decedents.
Our finding that the first ICU day is the most expensive is
consistent with most previous studies.6,17,18 The stability of
costs in days between admission and death/discharge is
similar to that observed in patients receiving mechanical
ventilation in the ICU for >48 hours who survived to ICU
discharge.6 Our study demonstrated that this pattern was
consistent and applicable to a broad group of ICU decedents,
across different ICUs and different clinical services. By
contrast, a recent study did not see higher day 1 costs in
patients admitted to medical/nonsurgical ICUs.19 This dif-
ference in findings may be due to severity of illness; ICU
mortality was not reported in this study, making it difficult to
determine if our cohorts are comparable.
One important implication of the stability of these cost
patterns is that the aging population (and accompanying in-
crease in Medicare coverage), and the concomitant increases
in chronic comorbidities, will increase ICU costs, but they are
FIG. 1. Average total ICU cost broken down by categories
of costs (n = 572). Under direct fixed costs, fixed represents
clinical department administrative fees and other represents
other overhead fees. ICU, intensive care unit.
Table 2. Intensive Care Unit Costs
Cost variablea Cost
Total costs
Total ICU cost, 1000 US$ 39.3 – 45.1
Median (IQR) 24.1 (10.4–51.9)
Total cost per ICU day, 1000 US$ 7.7 – 6.1
Median (IQR) 6.1 (4.9–8.4)
ICU admission day cost, 1000 US$ 9.6 – 7.6
Median (IQR) 6.9 (5.2–11.0)
ICU death day cost, 1000 US$ 2.0 – 3.1
Median (IQR) 1.0 (0.6–2.1)
Direct variable costs
Total direct variable ICU cost,
1000 US$
8.0 – 10.2
Median (IQR) 5.0 (1.6–9.9)
Total direct variable cost per
ICU day, 1000 US$
1.8 – 2.9
Median (IQR) 1.1 (0.6–2.0)
ICU admission day direct
variable cost, 1000 US$
2.5 – 3.5
Median (IQR) 1.1 (0.6–3.0)
ICU death day direct variable cost,
1000 US$
0.6 – 1.1
Median (IQR) 0.2 (0.1–0.5)
Data presented as mean – SD, unless otherwise indicated.
aAdjusted for inflation and reported in 2013 U.S. dollars.
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FIG. 3. Results of regression analyses stratified by length of stay, underlying cause of death, insurance type, type of ICU,
and clinical service. (A) Tests if, on average, costs are greater on admission day versus day 2; (B) tests if, on average, costs
are stable after the second day.
FIG. 2. Upper panel: ICU costs broken down by day of stay; Lower panel: Spine plot by day of stay, indicating relative
fraction of cost categories (n = 572).
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unlikely to change the pattern of ICU costs. Instead, policy
makers will have to turn to interventions such as ACP and
palliative care, which focus on preventing unwanted or
nonbeneficial ICU admissions and reducing ICU LOS by
matching medical care to individual patient preferences.
Our finding that direct fixed and indirect costs represent the
majority of total hospital costs is consistent with previous
studies.6,9,20 Our study found that the proportion of ICU costs
attributable to labor increased over the ICU stay and that
costs attributable to supplies decreased over time. From the
hospital’s perspective, over a short time horizon, direct fixed
and indirect costs are incurred regardless of LOS. However,
over a longer time horizon, fixed costs can become variable.7
Reducing ICU bed days over time may allow fixed expenses
attributable to the ICU to be reduced or, alternatively, allow a
reduction in the growth rate for ICU bed days.7 For example,
in our study, labor costs represented nearly 40% of total ICU
costs and nearly the entire portion of direct fixed costs. As-
suming that ICUs do not change ICU admission practices,21 a
reduction in inappropriate or unwanted ICU utilization may
prompt reductions in ICU staffing and labor costs.
Our results demonstrate that reducing LOS by preventing
an ICU admission versus shortening LOS by reducing days at
the end of a stay has very different cost implications. Pre-
venting the ICU admission all together will lead to signifi-
cantly greater savings; however, our finding that high total
ICU costs were associated with a higher percentage of costs
represented by supplies suggests that longer stay patients may
be an important focus for interventions to improve quality
and reduce costs.
Furthermore, the degree of hospital cost savings is largely
determined by the time horizon. In the short term, decreases
in ICU use are associated with savings in direct variable
costs, while in the long term, both direct variable and direct
fixed costs are potentially saved. Recent moves away from
fee-for-service toward more capitated payment models in-
crease the incentive for hospitals to realize these cost savings
and may represent an important opportunity for palliative care.
Under volume-based fee-for-service, in which more ICU
stays are profitable (reimbursement > cost), few financial
incentives exist from the hospital administrators’ perspective
to support interventions that reduce ICU admissions and
LOS, especially in the short term when the majority of costs
are fixed. However, our changing reimbursement systems
provide a greater sense of urgency to reduce unwanted ICU
utilization. Under bundled payment or episode-based pay-
ment systems, hospitals and physicians are reimbursed from
the same pool of funds based on the health condition of
the patient.22 This type of reimbursement policy provides
stronger financial incentives for both administrators and
physicians to decrease ICU usage since both bear some fi-
nancial risk for costly episodes. However, both the size of the
budget and the sharing of financial risk between physicians
and hospitals will depend on contract negotiations. Under
value-based performance, reimbursement is linked to im-
proving quality and reducing costs. Thus, even in the short
term when most ICU costs are fixed, but prevention of un-
wanted ICU stays is a quality measure, hospital administra-
tors may be incentivized to integrate ACP and palliative care
interventions to decrease ICU LOS, prevent unwanted ICU
stays, and match care with patient wishes. In fact, ICU LOS
has been proposed as a quality measure by the Joint Com-
mission, strengthening the incentive for adoption within
quality-based payment systems.23 Capitated payment sys-
tems and fixed global budgets, as recently passed in Mary-
land, provide a fixed budget per patient regardless of care
required, providing even more financial incentives for hos-
pitals to reduce overall costs with hospitals bearing more of
the financial burden for costly patients.
Several prior studies have demonstrated reductions in
overall hospital costs associated with inpatient palliative care
services.24 One study also found that palliative care consul-
tation was associated with reduced ICU costs25; however, to
our knowledge, no study to date has looked at the effect of
palliative care and ACP on ICU costs in the short term and
long term using direct variable, direct fixed, and indirect ICU
costs. This study provides insight into what patterns of ICU
cost look like for ICU decedents and potential savings that
may be realized in the short and long term.
Our study has several limitations. First, we acknowledge
that there is considerable variation in defining direct (variable
and fixed) and indirect costs. In addition, this study was
Table 3. Theoretical Cost Savings for Representative Patient with Severe COPD
Who Prefers Not To Die in the Intensive Care Unit
Intervention effecta
Direct variable
costs
Direct fixed
costs
Indirect
costs
Total
costs
Avoiding ICU admission
(advance care planning)
6.5 days avoided $6.2K (16%) $18.4K (48%) $13.8K (36%) $38.4K (100%)
Reducing ICU LOSb
(palliative care consultation
in the ICU)
Last 1.7 days of ICU
stay avoided
$1.3K (21%) $2.8K (46%) $2.0K (33%) $6.1K (100%)
Direct variable costs include supply and drug costs. Direct fixed costs include labor, administrative, and overhead fees. Indirect costs
represent services provided by cost centers not directly linked to patient care, such as information technology, environmental services, and
hospital administration.
aBased on mean LOS for patients in our cohort whose death was attributed to respiratory causes on death certificate and estimates of
effect of advance care planning and palliative care interventions according to current literature.26
bThese costs reflect the costs of the last 1.7 days of the ICU stay, taking into account the variation of cost by day of stay. These costs,
however, do not reflect the marginal difference between the last days in the ICU and the acute care floor as all patients in this cohort died in
the ICU.
LOS, length of stay.
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conducted in a single hospital and different hospitals may
have a different fee structure for direct and indirect costs as
well as different patterns of care. Additionally, this hospital
was the site of a system-level intervention to improve palli-
ative care in the ICU11 and thus estimates of cost reductions
may be conservative. Second, our analyses do not include
physician fees as these are generated from a separate orga-
nization and are unable to be broken down by day in the ICU;
thus, our cost estimates are conservative. However, this study
provides insights into the costs of terminal ICU care that can
help guide future studies. Third, our study describes costs for
diverse patients dying in the ICU and is not focused only on
patients for whom palliative care interventions are appro-
priate. Nonetheless, these cost findings provide guidance for
assessing the economic impact of implementing palliative
care interventions on ICU costs. Fourth, we recognize that
these findings do not provide information for conducting
analyses from the societal perspective. Furthermore, the
concept of cost shifting has not been factored in and thus
these figures represent the maximum potential cost saving.
Finally, data from this study were collected between 2003
and 2005 and should be replicated with more recent data. We
did not see changes in quality of palliative care in the ICU
between 2003 and 2008,26 but additional research should be
conducted to ascertain if patterns of costs are changing.
Our findings have important implications for palliative and
ICU care in the United States as we reduce volume-based fee-
for-service reimbursement and shift toward accountable care
organizations and value-based purchasing. Value in health-
care is key to controlling costs and improving quality. Most
importantly, these estimates provide insight into the range of
cost savings that may be realized with interventions such as
ACP and palliative care that help to align care with outcomes
desired by patients, such as dying outside of the hospital.
Future research, identifying cost patterns and implications
using additional institutions and more recent data, is needed
to inform clinicians as well as healthcare administrators and
policy makers.
All the authors attest that they do not have any potential or
actual personal or financial involvement with any company
or organization with financial interest in the subject matter.
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Appendix A
Regression models:
In each group, we used the following regression model:
E log daily ICU costð Þj day, deathf g¼ b0þ b1 day¼ 1ð Þþ b2
day> 2ð Þþ b3 day> 2 and death¼ 1ð Þþ b4 day> 2  dayð Þ.
This model parameterizes an overall mean of log ICU costs
on day 1 (b0þ b1) and day 2 b0ð Þ regardless of whether a
subject died on that day. The model also uses a straight line
with slope b4 to describe the trend in average log-costs after
day two. Death days are cheaper on average, simply due to
the fact that a full day is not spent in the ICU on that day. To
account for this, we allow a separate intercept for death days
by including b3.
To test whether costs on the first day are more expensive
than the second, we test the null hypothesis H0 : exp (b1)¼ 1,
noting exp b1ð Þ may be interpreted as the ratio of geometric
mean costs comparing day one to day two, with values greater
than one indicating greater average costs on day one. The
geometric mean is simply the exponentiated mean of the log-
transformed data. The geometric mean is less sensitive to
extreme cost values than the usual arithmetic mean and
thus may be a better representation of the central tendency
of costs.
In order to determine an appropriate test for determining
whether costs are stable after the second day in the ICU, first
note that exp (b4) can be interpreted as the per-day multi-
plicative change in average daily ICU costs. Thus, if costs
were completely stable after day two on average, exp b4ð Þ
would equal one. Standard hypothesis tests would assess
evidence against the null hypothesis H0 : exp b3ð Þ¼ 1;
however, a lack of evidence against this null hypothesis is
not necessarily evidence in favor of it. A more appropriate
procedure is an equivalence test that examines evidence
against two one-sided null hypotheses, H01 : exp (b4) < l and
H02 : exp b4ð Þ > u. Here, l < 1 and u > 1 are user-specified
lower and upper bounds that together define a range of values
for which costs may be claimed to be clinically equivalent.
Rejecting these null hypotheses thus provides the desired
statistical evidence that l < exp (b4) < u. We set these to be
0.960 and 1.032, which would imply a 25% change in costs
over a one-week time period; this can be seen by noting
0:9607¼ 0:75 and 1:0327¼ 1:25. That is, if, based on the
slope of the line fit to average costs after day two, daily costs
are predicted to have changed by less than 25% over a week’s
time, we declare those costs to be clinically equivalent.
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